Influenced by robust demand, the cumulative sales of Dong-A’s Stillen and SK Chemicals’ Joins have posted 404.5 billion won since their launching since 2002, according to the Ministry of Health and Welfare.
So far, Korea has developed a total of 17 new drugs, but none of them sold brilliant sales.
With multinationals taking up three-quarters of the local drug market, market insiders said ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.